Several multicenter benchmark data sets represent valuable steps toward using RNA-seq as a diagnostic tool with clinical utility.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
MAQC Consortium. Nat. Biotechnol. 28, 827–838 (2010).
SEQC/MAQC-III Consortium. Nat. Biotechnol. doi:10.1038/nbt.2957 (24 August 2014).
Li, S. et al. Nat. Biotechnol. doi:10.1038/nbt.3000 (24 August 2014).
Wang, C. et al. Nat. Biotechnol. doi:10.1038/nbt.3001 (24 August 2014).
Li, S. et al. Nat. Biotechnol. doi:10.1038/nbt.2972 (24 August 2014).
Risso, D., Ngai, J., Speed, T.P. & Dudoit, S. Nat. Biotechnol. doi:10.1038/nbt.2931 (24 August 2014).
Gargis, A.S. et al. Nat. Biotechnol. 30, 1033–1036 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Van Keuren-Jensen, K., Keats, J. & Craig, D. Bringing RNA-seq closer to the clinic. Nat Biotechnol 32, 884–885 (2014). https://doi.org/10.1038/nbt.3017
Published:
Issue date:
DOI: https://doi.org/10.1038/nbt.3017
